Delivery Order SPE2DB22D1106-SPE2DB24FEYF5
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,673.92 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG tablets. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,919.25 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG Tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,123.50 firm fixed-price delivery order is for the supply of the drug XELJANZ 5 MG TABLET UU 60S and does not have a set-aside designation. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $22,536.78 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,839.84 firm fixed price delivery order is for the provision of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, providing a wide range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of XELJANZ XR 11 MG TABLET in quantities of 30 tablets. The $9,890.97 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense (DoD). The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.90 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty medication. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,728.18 firm-fixed-price delivery order is for the supply of XELJANZ 5 MG TABLET, a prescription medication. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,240.29 delivery order is for the supply of XELJANZ 5 MG TABLET, a prescription medication used to treat certain autoimmune conditions. The contract has a firm fixed price and an ultimate completion date of December 2, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,279.76 firm fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...